Back to full portfolio

Adimab

Market-leading antibody drug discovery platform.
WEBSITE
Founder(s)
Tillman Gerngross
SECTOR(S)
Healthcare
Investment Stage
Growth
Status
Private
AdimabPlay Icon

More about Adimab

Perspectives

2023 Update on Clinical Pipeline

Read more
Adimab

2023 Update on Clinical Pipeline

Read more
Perspectives

Provides Year-End Update on 2023 Partnership Activities

Read more
Adimab

Provides Year-End Update on 2023 Partnership Activities

Read more
Perspectives

Adimab Update 2025

Read more
Adimab

Adimab Update 2025

Read more